242 related articles for article (PubMed ID: 28440057)
21. siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.
Hasan R; Chauhan SS; Sharma R; Ralhan R
World J Gastroenterol; 2012 Aug; 18(31):4127-35. PubMed ID: 22919244
[TBL] [Abstract][Full Text] [Related]
22. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
23. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway.
Shen Z; Xu L; Li J; Zhang N
Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.
Wang SQ; Wang X; Zheng K; Liu KS; Wang SX; Xie CH
Biochem Biophys Res Commun; 2017 Nov; 493(1):534-541. PubMed ID: 28867195
[TBL] [Abstract][Full Text] [Related]
25. Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.
Wang X; Li X; Li C; He C; Ren B; Deng Q; Gao W; Wang B
Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):520-7. PubMed ID: 27125974
[TBL] [Abstract][Full Text] [Related]
26. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling.
Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W
Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918
[TBL] [Abstract][Full Text] [Related]
27. Sporamin suppresses growth of human esophageal squamous cell carcinoma cells by inhibition of NF‑κB via an AKT‑independent pathway.
Qian CJ; Qi YX; Chen XY; Zeng JP; Yao J
Mol Med Rep; 2017 Dec; 16(6):9620-9626. PubMed ID: 29039512
[TBL] [Abstract][Full Text] [Related]
28. Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling.
Wen L; Mao W; Xu L; Cai B; Gu L
Chem Biol Drug Des; 2022 Jan; 99(1):118-125. PubMed ID: 34411455
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma.
Sekino N; Kano M; Matsumoto Y; Sakata H; Akutsu Y; Hanari N; Murakami K; Toyozumi T; Takahashi M; Otsuka R; Yokoyama M; Shiraishi T; Okada K; Hoshino I; Iida K; Akimoto AK; Matsubara H
Cancer Sci; 2018 Apr; 109(4):1066-1074. PubMed ID: 29396886
[TBL] [Abstract][Full Text] [Related]
30. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer.
Min HY; Yun HJ; Lee JS; Lee HJ; Cho J; Jang HJ; Park SH; Liu D; Oh SH; Lee JJ; Wistuba II; Lee HY
Mol Cancer; 2015 Jun; 14():113. PubMed ID: 26041671
[TBL] [Abstract][Full Text] [Related]
31. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G
Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171
[TBL] [Abstract][Full Text] [Related]
32. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
Chen C; Ma Z; Zhang H; Liu X; Yu Z
Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU.
Hatata T; Higaki K; Tatebe S; Shomori K; Ikeguchi M
Dis Esophagus; 2012; 25(8):716-22. PubMed ID: 22292507
[TBL] [Abstract][Full Text] [Related]
34. Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy.
Ma W; Zhang T; Pan J; Shi N; Fan Q; Wang L; Lu SH
Oncol Rep; 2014 Oct; 32(4):1601-9. PubMed ID: 25175038
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
36. Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways.
Cao J; Lv W; Wang L; Xu J; Yuan P; Huang S; He Z; Hu J
Cell Death Dis; 2018 Jul; 9(8):817. PubMed ID: 30050135
[TBL] [Abstract][Full Text] [Related]
37. β-Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-κB Signaling Pathway.
Zhu X; Zhang Y; Li Q; Yang L; Zhang N; Ma S; Zhang K; Song J; Guan F
J Biochem Mol Toxicol; 2016 Mar; 30(3):148-57. PubMed ID: 26733226
[TBL] [Abstract][Full Text] [Related]
38. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.
Peng Y; Zhou Y; Cheng L; Hu D; Zhou X; Wang Z; Xie C; Zhou F
Biochem Biophys Res Commun; 2015 Sep; 465(1):137-44. PubMed ID: 26235881
[TBL] [Abstract][Full Text] [Related]
39. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
40. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
